LOXair LLC Launches Advanced Respiratory Device Utilizing Space Technology
LOXair LLC announces the introduction of its PRESSURMAXX technology for respiratory therapy, leveraging advanced space-derived tank innovations. This initiative aims to address a gap in pediatric respiratory solutions, with a swift market entry planned following capital raising efforts.
Theia Market Signal Identification - AI Assisted
LOXair LLC, a new med tech company based in Torrance, CA, is set to enhance respiratory therapeutics with its PRESSURMAXX technology. This pressure vessel technology, derived from Type V tanks developed by Scorpius Space Launch Company (SSLC) for lunar lander propulsion, allows for a lightweight and compliant breathing apparatus targeting pediatric patients.
The technology's efficiency, demonstrated through successful lunar missions, is expected to significantly improve mobility and safety for first responders as well. The company is currently raising capital to expedite its market entry schedule, addressing an urgent need for innovative respiratory solutions.
Comments